{
    "clinical_study": {
        "@rank": "10103", 
        "arm_group": {
            "arm_group_label": "Electronic Skin Surface Brachytherapy", 
            "arm_group_type": "Experimental", 
            "description": "The patient will undergo quality of life assessment and skin imaging (ultrasonography and reflectance confocal microscopy). Brachytherapy will be performed over 6 outpatient visits over 2-3 weeks, on non-consecutive days. Patients will then be followed for 5 years."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to test the effectiveness of electronic skin surface\n      brachytherapy (ESSB) for early stage basal or squamous cell carcinoma of the skin using a\n      new device. This new device is Nucletron's Esteya Electronic Skin Surface Brachytherapy\n      System. The investigators want to understand what effects, good and/or bad this device for\n      delivering brachytherapy has on your skin cancer. The investigators also want to test the\n      safety, cosmetic results, and effects that ESSB has on quality of life."
        }, 
        "brief_title": "Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma", 
        "condition": [
            "Cutaneous Basal Cell", 
            "Squamous Cell Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Squamous Cell"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men or women \u2265 60 years old with estimated life expectancy of \u2265 5 years\n\n          -  Histopathologic diagnosis of basal or squamous cell carcinoma\n\n          -  Clinical stage T1N0M0 (by AJCC 2010 criteria)\n\n          -  Low risk features (by NCCN criteria)\n\n          -  Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 (Appendix C)\n\n          -  Able and willing to complete the Skindex16 and Skin Cancer Index (must be able to\n             speak English)\n\n          -  Skin lesion is visible on skin imaging (reflectance confocal microscopy and\n             ultrasonography\n\n          -  Ability to provide informed consent\n\n        Exclusion Criteria:\n\n          -  BCC/SCC that was previously treated (ie, recurrent BCC/SCC)\n\n          -  BCC/SCC in region adjacent to or overlapping with region of prior radiotherapy\n\n          -  BCC/SCC on irregular surface (ie, target area not flat)\n\n          -  BCC/SCC adjacent to or overlapping with burn or scar\n\n          -  BCC/SCC in area prone to trauma (including, but not limited to the skin overlying the\n             tibia, dorsum of hands and elbow)\n\n          -  BCC/SCC in area with compromised lymphatic drainage or vascular supply\n\n          -  BCC/SCC within 5 cm of another treated or untreated BCC/SCC\n\n          -  Inflammatory process in target area\n\n          -  Collagen vascular disease (lupus, scleroderma, rheumatoid arthritis)\n\n          -  Diabetes that is poorly controlled\n\n          -  Genetic disorder predisposing patient to skin cancers or radiation sensitivity (basal\n             cell nevus syndrome, xeroderma pigmentosum, ataxia telangiectasia mutans)\n\n          -  Receipt of treatment with another investigational device or drug\n\n          -  Receipt of drug that will affect biologic response to radiation (radiosensitizer or\n             radioprotector)\n\n          -  High likelihood of protocol non-compliance (in opinion of investigator)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "29", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02131805", 
            "org_study_id": "14-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Electronic Skin Surface Brachytherapy", 
                "intervention_name": "Electronic Skin Surface Brachytherapy", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": "Electronic Skin Surface Brachytherapy", 
                "intervention_name": "Quality of life assessment", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "skin", 
            "Brachytherapy", 
            "14-001"
        ], 
        "lastchanged_date": "May 5, 2014", 
        "link": {
            "description": "Memorial Sloan Kettering Cancer Center", 
            "url": "http://www.mskcc.org/"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Michael Kasper, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Boca Raton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33486"
                    }, 
                    "name": "Lynn Cancer Institute"
                }, 
                "investigator": {
                    "last_name": "Michael Kasper, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christopher Barker, MD", 
                    "phone": "212-639-8168"
                }, 
                "contact_backup": {
                    "last_name": "Michael Zelefsky, MD", 
                    "phone": "212-639-6802"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Memorial Sloan Kettering Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Christopher Barker, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot Study of Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma", 
        "overall_contact": {
            "last_name": "Christopher Barker, MD", 
            "phone": "212-639-8168"
        }, 
        "overall_contact_backup": {
            "last_name": "Michael Zelefsky, MD", 
            "phone": "212-639-6802"
        }, 
        "overall_official": {
            "affiliation": "Memorial Sloan-Kettering Cancer Center", 
            "last_name": "Christopher Barker, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Efficacy will be measured by local control of the irradiated BCC/SCC 3 years after brachytherapy.", 
                "measure": "efficacy of Electronic Skin Surface Brachytherapy (ESSB)", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }, 
            {
                "description": "Cosmetic outcome will be patient-reported and clinician-assessed after brachytherapy.", 
                "measure": "assess the cosmetic outcome of ESSB", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02131805"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "(grade 1-4 adverse events). The study will use the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 for assessing toxicity related to brachytherapy.", 
                "measure": "severity of adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "3 years"
            }, 
            {
                "description": "Patient reported health-related quality of life outcomes will be assessed using the Skindex-16 (Appendix A) and the Skin Cancer Index (Appendix B).", 
                "measure": "reported quality of life", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }
        ], 
        "source": "Memorial Sloan-Kettering Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Lynn Cancer Institute", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Memorial Sloan-Kettering Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}